Introduction to the 'MAH Public Holding' Service Management Platform

　　Those who do research and development, sell drugs, and make drugs...

　　The drugs that sell well have been cut off by the manufacturer (frustrated and angry);

　　After so many years of technical development, the results were sold to others (reluctant but must let go);

　　There are high-end factories, but no good products to keep the production line busy (hard to endure)...

　　So, do you also want to 'have your own son' and have a good variety that belongs to you? Enjoy the continuous profits brought by product sales?

　　Perhaps you have technology, but not enough money;

　　Perhaps you have a market with a full wallet, but you don't want to worry about other things;

　　Perhaps you don't know what variety to develop to sustain your pharmaceutical factory;

　　Or perhaps after so many years of making raw materials, you also want to make a formulation and sell it;

　　And perhaps you have this and that, but you're worried about taking big risks yourself...

　　Stop hesitating, come here—MAH Joint Holding Service Management Platform

　　This platform operates as a business, so you don't have to worry about it being 'empty'. Since it operates as a business, we must have our selling points that can meet your needs.

　　You can continue reading:

　　The platform was founded by professionals with over 20 years of experience in the pharmaceutical industry. The initiators have extensive experience in product project establishment, pharmaceutical company investment mergers and acquisitions, and pharmaceutical factory management.

　　The shareholder companies Beijing Haibu Pharmaceutical Technology Co., Ltd. and Jinan Tonglu Pharmaceutical Technology Development Co., Ltd. have professional pharmaceutical research and development teams, standardized experimental facilities, first-class research and development instruments and equipment, as well as a complete research and development quality management system. Moreover, there are technical experts involved. Importantly, there are also invested pharmaceutical factories with production capabilities.

　　Of course, there are things we don't have; however, there is still you, him, and 'her'. With sincere hearts and good project proposals, we won't lack him or 'her'.

　　Therefore, we set up this platform to invite those interested in MAH participation—whether they are research institutions, clinical institutions, pharmaceutical companies, commercial companies or raw material drug enterprises—as long as you want to participate.

　　'Come on', bring your projects along with your ideas; of course bringing money is even better. Let's embark on the path of MAH joint holders together; this is a bright road for those in the pharmaceutical industry—clearing paths when encountering mountains and building bridges when meeting water...

　　(Beijing) Zhongxin Technology Co., Ltd./ 'MAH Joint Holding' Service Management Platform

　　'Product Project Establishment and Consultation'

　　'Project Overall Management during R&D Phase'

　　'Establishment of GMP Quality Management System'

　　'Establishment of Supply Chain Management System'

　　'Cooperation Consultation: +86-139-1172-1928'